These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 26118642)

  • 41. IKK interacts with rictor and regulates mTORC2.
    Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
    Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology of chaperone-mediated autophagy.
    Massey A; Kiffin R; Cuervo AM
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2420-34. PubMed ID: 15325582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chaperone-Mediated Autophagy.
    Yang Q; Wang R; Zhu L
    Adv Exp Med Biol; 2019; 1206():435-452. PubMed ID: 31776997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oncogenic suppression of PHLPP1 in human melanoma.
    Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST
    Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy.
    Ferreira JV; Fôfo H; Bejarano E; Bento CF; Ramalho JS; Girão H; Pereira P
    Autophagy; 2013 Sep; 9(9):1349-66. PubMed ID: 23880665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1.
    Suzuki J; Nakajima W; Suzuki H; Asano Y; Tanaka N
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1334-1340. PubMed ID: 27939888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer.
    Hubert V; Weiss S; Rees AJ; Kain R
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.
    Wang H; Tian C; Sun J; Chen LN; Lv Y; Yang XD; Xiao K; Wang J; Chen C; Shi Q; Shao QX; Dong XP
    Mol Neurobiol; 2017 Aug; 54(6):4401-4413. PubMed ID: 27344333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
    Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
    Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methods to monitor chaperone-mediated autophagy.
    Kaushik S; Cuervo AM
    Methods Enzymol; 2009; 452():297-324. PubMed ID: 19200890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Multifaceted Role of CMA in Glioma: Enemy or Ally?
    Lo Dico A; Martelli C; Diceglie C; Ottobrini L
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Connecting chaperone-mediated autophagy dysfunction to cellular senescence.
    Moreno-Blas D; Gorostieta-Salas E; Castro-Obregón S
    Ageing Res Rev; 2018 Jan; 41():34-41. PubMed ID: 29113832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure of transmembrane domain of lysosome-associated membrane protein type 2a (LAMP-2A) reveals key features for substrate specificity in chaperone-mediated autophagy.
    Rout AK; Strub MP; Piszczek G; Tjandra N
    J Biol Chem; 2014 Dec; 289(51):35111-23. PubMed ID: 25342746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A photoconvertible fluorescent reporter to track chaperone-mediated autophagy.
    Koga H; Martinez-Vicente M; Macian F; Verkhusha VV; Cuervo AM
    Nat Commun; 2011 Jul; 2():386. PubMed ID: 21750540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chaperone-assisted degradation: multiple paths to destruction.
    Kettern N; Dreiseidler M; Tawo R; Höhfeld J
    Biol Chem; 2010 May; 391(5):481-9. PubMed ID: 20302520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy.
    Liu Y; Tan L; Tan MS
    Mol Cell Biochem; 2023 Oct; 478(10):2173-2190. PubMed ID: 36695937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early cellular changes after blockage of chaperone-mediated autophagy.
    Massey AC; Follenzi A; Kiffin R; Zhang C; Cuervo AM
    Autophagy; 2008 May; 4(4):442-56. PubMed ID: 18253088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy.
    Saha T
    Autophagy; 2012 Nov; 8(11):1643-56. PubMed ID: 22874552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.
    Shao Y; Ren W; Dai H; Yang F; Li X; Zhang S; Liu J; Yao X; Zhao Q; Sun X; Zheng Z; Xu C
    Mol Cells; 2023 Jun; 46(6):360-373. PubMed ID: 36694914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.